CAGE Bio, Inc., a biotechnology firm in clinical development focusing on novel treatments for prevalent immuno-dermatological conditions, announced the start of a phase 2b dose-ranging study for its CGB-500 product. This topical JAK inhibitor...
Telix Pharmaceuticals Limited has announced that it has signed an asset purchase agreement with antibody engineering firm ImaginAb, Inc. (ImaginAb) to obtain a pipeline of next-generation therapeutic candidates, an innovative proprietary biologics...
Pharma lobby group Federation of Pharma Entrepreneurs (FOPE) has urged the government to extend the deadline for compliance with the revised Schedule M by two years. This comes as the government is nearing finalisation of a draft notification...
Gilead Sciences, Inc. and LEO Pharma announced a strategic alliance aimed at speeding up the development and marketing of LEO Pharma’s small molecule oral STAT6 (signal transducer and activator of transcription 6) initiatives for the possible...
Mineralys Therapeutics, Inc., a biopharmaceutical company in clinical development concentrating on creating therapies for hypertension, chronic kidney disease (CKD), and other ailments linked to dysregulated aldosterone, revealed that the US Food...
The World Health Organization (WHO) has prequalified the initial diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, which can assist in the safe administration of WHO-approved treatments to prevent recurrence of Plasmodium...
ModeX Therapeutics Inc, announces that the first participant has been dosed in the phase I trial (NCT06655324) of an Epstein-Barr virus (EBV) vaccine candidate being developed alongside Merck, referred to as MSD outside the U.S. and Canada...
Roche announced that its complete slide imaging system, Roche Digital Pathology Dx, has obtained an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA). This approval alters the one Roche obtained on June 14, 2024, for Ro...
Increased investment in public healthcare, incentives for research and development, and tax breaks for additional life-saving medications are among the key demands of executives in the pharmaceutical and hospital sectors as they approach the...
US pharmaceutical giant Eli Lilly and Company announced that it intends to set up a new global capability center in Hyderabad. The organization plans to hire over 1,000 to 1,500 highly skilled individuals, including technology engineers and data...
, CDSCO.jpg)
